Literature DB >> 8951611

Changes in isotype composition and antigen recognition of anti-Trypanosoma cruzi antibodies from acute to chronic Chagas disease.

E S Umezawa1, M A Shikanai-Yasuda, A M Stolf.   

Abstract

This report describes differences in humoral immune response of acute and chronic phases of human Chagas disease. The reactivities of IgG, IgM, and IgA anti-Trypanosoma cruzi antibodies in serum samples from both groups of patients were compared by enzyme-linked immunosorbent assay (ELISA) employing either one of four antigenic fractions: mouse laminin (LAM), which reacts through Gal alpha 1-3Gal epitopes expressed on trypomastigote surface: whole intact trypomastigotes (TCT); trypomastigotes excreted/secreted antigens (TESA); and epimastigote alkaline extract (EAE). The selection of T. cruzi antigen preparations was based on their relative content of surface and internal antigens found in trypomastigote forms. The proportion of IgG reactive to carbohydrate epitopes was assessed through the decay of IgG reactivity from acute and chronic sera after m-periodate oxidation of solid-phase bound antigens. Trypomastigote and TESA antigens recognized by IgG from acute and chronic sera were also compared by immunoblotting. ELISA and immunoblotting data showed that: (1) the proportion of IgG directed to trypomastigote surface antigens was higher in acute than in chronic sera, whereas the opposite was found for internal antigens, (2) acute sera contained a higher percentage of IgG reactive to trypomastigote carbohydrate epitopes than chronic sera, and (3) anti-T. cruzi IgA was found exclusively in acute sera and led to 100% positivity when LAM, TCT, and TESA were employed as antigens. IgA ELISA with these antigens and IgG immunoblotting pattern with TESA could be useful as serological markers for the acute phase of human Chagas disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8951611     DOI: 10.1002/(SICI)1098-2825(1996)10:6<407::AID-JCLA16>3.0.CO;2-0

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  13 in total

1.  Excretory-secretory antigens of Trypanosoma cruzi are potentially useful for serodiagnosis of chronic Chagas' disease.

Authors:  M Nakazawa; D S Rosa; V R Pereira; M O Moura; V C Furtado; W V Souza; M N Barros; F G Abath; Y M Gomes
Journal:  Clin Diagn Lab Immunol       Date:  2001-09

2.  Characterization and Diagnostic Application of Trypanosoma cruzi Trypomastigote Excreted-Secreted Antigens Shed in Extracellular Vesicles Released from Infected Mammalian Cells.

Authors:  Norma L Bautista-López; Momar Ndao; Fabio Vasquez Camargo; Takeshi Nara; Takeshi Annoura; Darryl B Hardie; Christoph H Borchers; Armando Jardim
Journal:  J Clin Microbiol       Date:  2016-12-14       Impact factor: 5.948

Review 3.  Chagas Disease Diagnostic Applications: Present Knowledge and Future Steps.

Authors:  V Balouz; F Agüero; C A Buscaglia
Journal:  Adv Parasitol       Date:  2016-11-14       Impact factor: 3.870

4.  Purified excreted-secreted antigens from Trypanosoma cruzi trypomastigotes as tools for diagnosis of Chagas' disease.

Authors:  Mariolga Berrizbeitia; Momar Ndao; José Bubis; Marcelo Gottschalk; Alberto Aché; Sonia Lacouture; Mehudy Medina; Brian J Ward
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

5.  Serodiagnosis of American trypanosomosis by using nonpathogenic trypanosomatid antigen.

Authors:  V M Monteón; L Guzmán-Rojas; C Negrete-García; J L Rosales-Encina; P A Lopez
Journal:  J Clin Microbiol       Date:  1997-12       Impact factor: 5.948

6.  Reactivity of chagasic antigal antibodies with noninfected cells treated with Trypanosoma cruzi secreted/excreted antigens.

Authors:  J K Yokoyama-Yasunaka; R M Piazza; E S Umezawa; A M Stolf
Journal:  J Clin Lab Anal       Date:  1998       Impact factor: 2.352

Review 7.  A systematic review of high quality diagnostic tests for Chagas disease.

Authors:  Anna M Afonso; Mark H Ebell; Rick L Tarleton
Journal:  PLoS Negl Trop Dis       Date:  2012-11-08

8.  Human Trypanosoma cruzi infection and seropositivity in dogs, Mexico.

Authors:  Jose G Estrada-Franco; Vandanajay Bhatia; Hector Diaz-Albiter; Laucel Ochoa-Garcia; Alberto Barbabosa; Juan C Vazquez-Chagoyan; Miguel A Martinez-Perez; Carmen Guzman-Bracho; Nisha Garg
Journal:  Emerg Infect Dis       Date:  2006-04       Impact factor: 6.883

9.  Molecular characterization of Trypanosoma cruzi SAP proteins with host-cell lysosome exocytosis-inducing activity required for parasite invasion.

Authors:  Tamiris Zanforlin; Ethel Bayer-Santos; Cristian Cortez; Igor C Almeida; Nobuko Yoshida; José Franco da Silveira
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

10.  Different serological cross-reactivity of Trypanosoma rangeli forms in Trypanosoma cruzi-infected patients sera.

Authors:  Milene H de Moraes; Alessandra A Guarneri; Fabiana P Girardi; Juliana B Rodrigues; Iriane Eger; Kevin M Tyler; Mário Steindel; Edmundo C Grisard
Journal:  Parasit Vectors       Date:  2008-07-08       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.